Gapping down
In reaction to disappointing earnings/guidance:
- FDX -10.7%, CHWY -4%, ADBE -2.7%, GIS -1.9%, STLD -1.3%
Other news:
- TBIO -10.4% (prices offering of 9 mln shares of its common stock at a public offering price of $10.00 per share)
- PTCT -7.9% (commences public offering of $100 mln of shares of common stock and $250 mln convertible senior notes due 2026 )
- IOTS -7.8% (proposes private offering of convertible senior notes due 2024)
- ZYNE -5.2% (announces "positive" top line results from the open label Phase 2 BELIEVE 1 clinical trial)
- CTST -3.9% (extending move lower after announcing Health Canada suspended its license)
- ACAD -3.5% (prices underwritten public offering of 6.25 mln shares of its common stock at a price to the public of $40.00 per share)
- CBAY -3.4% (announces departure of Chief Medical Officer Pol Boudes, M.D.)
- UPS -3.1% (following FDX earnings/guidance)
- WLL -1.8% (extending yesterday's 16% move lower)
- ALXN -1.3% (announces CFO transition; Paul Clancy to be succeeded by Aradhana Sarin, M.D. after filing of Q3 results)
Analyst comments:
- N/A.